Drug metabolism and individualized medicine

Current Drug Metabolism

Volumn 4, Issue 1, 2003, Pages 33-44

  Srivastava, Pratima ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMONAFIDE; ANTIARRHYTHMIC AGENT; APOLIPOPROTEIN E; ARACHIDONATE 5 LIPOXYGENASE; ATRELEUTON; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME P450; DAPSONE; DRUG METABOLIZING ENZYME; ESTROGEN DERIVATIVE; FLUOROURACIL; GLUCURONOSYLTRANSFERASE; IRINOTECAN; ISONIAZID; NITRITE; NITROFURANTOIN; PRIMAQUINE; PROPAFENONE; SULFONAMIDE; TACRINE; THIOPURINE METHYLTRANSFERASE; TRASTUZUMAB; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; WARFARIN;

ALZHEIMER DISEASE; ASTHMA; BIOTRANSFORMATION; BREAST CANCER; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; DEPRESSION; DIARRHEA; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG EXCRETION; DRUG METABOLISM; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DRUG WITHDRAWAL; GENOTYPE; HEMOLYTIC ANEMIA; HUMAN; LIVER TOXICITY; METHEMOGLOBINEMIA; NAUSEA AND VOMITING; NEUROTOXICITY; PAIN; PERIPHERAL NEUROPATHY; PHARMACOGENETICS; PHARMACOGENOMICS; PHENOTYPE; POSTMARKETING SURVEILLANCE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; GENOME, HUMAN; HUMANS; PATIENT CARE PLANNING; PATIENT PARTICIPATION; PHARMACEUTICAL PREPARATIONS; PHARMACOGENETICS;

EID: 0037306343     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/1389200033336829     Document Type: Review

References (83)

1. The International SNP Map Working Group (2001) Nature, 409, 860-921.
2. Lazarou, J., Pomeranz, B.H., and Corey P.N. (1998). JAMA, 279, 1200-1205.
3. Venning, G. (1983) British Medical Journal, 286, 199-206.
4. Nebert, D.W. (1997) Am. J. Hum. Genetics, 60, 265-271.
5. Beutler, E. (1991) New England J. Medicine, 324, 169-174
6. http://www.pharmabiz.com/achieves and F.D.C. reports.
7. Liebeg, J. (1842) Ann. Chem. Pharm., 44, 345
8. Wohler, F. (1824) Tiedemann's Z. Physiol., 1, 142.
9. Ure, A. (1841) Phar. J. Transact., 1,346.
10. Lu, A.Y.H. (1998) Drug Metab. and Dis., 26, 1217-1222.
11. Williams, R.T. (1959) Detoxication Mechanisms. Publishers John Wiley & Sons Inc. N.Y.
12. Omura, T. and Sato, R. (1964) J. Biol. Chem., 239, 2370.
13. Rendic, S. and Di Carlo, F.J. (1997). Drug Metab. Rev., 29, 413-580.
14. Spatzenegger, M. and Jaeger, W. (1995) Drug Metab. Rev., 27, 397-417.
15. Weatherall, M. (1982) Nature, 296, 387-390.
16. Tucker, G.T. (1992) Int. J. Clin. Pharmacy. Ther. Toxicol., 30, 550-553.
17. Brockton, N., Little, J., Sharp, L. and Cotton, S.C. (2000) Am. J. Epidemiol., 151, 846-861.
18. Parkinson, A. (1996) Toxicol. Pathol., 24, 45-57.
19. Lamba, V., Lamba, J.K., Dilwari, J.B. and Kohli, K.K. (1998) Eur. J. Clin. Pharmacol., 54, 787-791.
20. Rebbeck, T.R., Jaffe, J.M., Walker, A.H., Wein, A.J. and Malkowicz, S.B. (1998) J. Natl. Cancer Inst., 90, 1225-1229.
21. Ruas, J.L. and Lechner, M.C. (1997) Pharmacogenetics, 7, 333-335.
22. Nasu, K., Kubota, T. and Ishizaki, T. (1997) Pharmacogenetics, 7, 405-409.
23. Wrighton, S.A., Vandenbranden, M., Stevens, J.C., Shipley, L.A., Ring, B.J., Rettie, A.E. and Cashman, J.R. (1993). Drug Metab. Rev., 25, 453-484.
24. Rendic, S. and Di carlo, F.J. (1997) Drug Metab. Rev., 29, 413-580.
25. Thummel, K.E., Kunze, K.L. and Shen, D.D. (1997) Adv. Drug Delivery Rev., 27, 99-127
26. Newton, D.J., Wang, R.W. and Lu, A.Y.H. (1995) Drug Metab. Dispos., 23, 154-158.
27. Koppanyi, T. and Avery, M. (1966). Clin. Pharmacol. Therap., 7, 250-267.
28. Rodrigues, A.D. (1997) Pharm. Res., 14, 1504-1510.
29. Ingel Sundberg, M., Oscaron,M. and McLellan, R.A. (1999) Trends Pharmacol. Sci., 20, 342-349.
30. Meyer, U. and Zanger, U.M. (1997) Ann. Rev. Pharmacol. Toxicol., 37, 269-296.
31. Touw, D.J. (1997) Drug Metab. Drug Interact., 14, 55-82.
32. Delomenie, C., Sica, L., Grant, D.M., Krishnamoorthy,R. and Dupret, J.M. (1996) Pharmacogenetics, 6, 177-185.
33. Simon, T., Becquemont, L., Mary-Krause, M., de Waziers, I., Beaune, P., Funck-Brentano, C. and Jaillon, P. (2000) Clin. Pharmacol. Ther., 67, 432-437.
34. Eichelbaum, M. and Gross, A.S. (1990) Pharmacol. Ther., 46, 377-394.
35. Freeman, B.D., Reaume, A.G., Swanson,P.E., Epstein, C.J., Carlson, E.J., Buckman, T.G., Karle,I.E. and Hotchkiss, R.S. (2000) Crit. Care Med, 28, 1701-1708.
36. Elion, G.B. (1989) Science, 244, 41-47.
37. Innocenti, F. and Ratain, M.J. (2002) Eur. J. Cancer, 68, 639-644.
38. Hoffmeyer, S., Burk, O., von Richter, O., Arnold, H.P., Brockmoller, J., Johne, A., Cascorbi, I., Gerloff, T., Roots, I., Eichelbaum, M. and Brinkmann, U. (2000) Proc. Natl. Acad. Sci. USA, 97, 3473-3478.
39. Mccarthy, T.V., Quane, K.A. and Lynch, P.J. (2000) Hum. Mutat., 15, 410-417.
40. Knowles, S.R., Uetrecht, J., Shear, N.H. (2000) Lancet, 356, 1587-1591.
41. Vesell, E.S. (1997) Annals of Internal Medicine, 126, 653-655.
42. Obach, R.S., Baxter, J.G., Liston, T.E., Silber, B.M., Jones, B.C., MacIntyre, F., Rance, D.J. and Wastall, P., (1997) J. Pharmacol. Exp. Ther., 283, 46-58.
43. Evans, D.A.P. Genetic factors in drug therapy. In: Clinical and Molecular Pharmacogenetics. Cambridge: Cambridge University Press; 1993.
44. Garrod, A.E. (1902) Lancet, ii, 1616-1620.
45. Shimada, T., Yamazka, H., Mimura, M., Inui, Y. and Guengerich, F.P. (1994) J. Pharmacol. Exp. Ther., 270, 414-423.
46. Hall, M.J., Bortoshuk, L.M., Cain, W.S. and Stevens, J.C. (1975) Nature, 253, 442-443.
47. Keller, D.F. (1970) CRC Crit. Rev. Clin. Lab. Sci., 2, 247-302.
48. Price-Evans, D.A. (1989) Pharmacol. Ther., 42, 157-234.
49. Vogel, F. (1959) Ergib. Inn. Kinderheild, 12, 52-125.
50. Kalow, W. (1962) Pharmacogenetics- Heredity and the responses to drugs. W.B. Saunders Company
51. Bailey, D.S., Bondar, A. and Furness, L.M. (1998) Current opinion in Biotechnology, 9, 595-601.
52. Adam, G.I. (2001) Current Opinion Drug discovery Development, 4, 296-300.
53. Lamba, V., Dhiman, R.K. and Kohli, K.K. (2000) Clin. Pharmacol. Ther., 68, 328-335.
54. Nebert, D.W. (2000) Eur. J. Pharmacol., 410, 107-120.
55. Doshi, B.S., Kulkarni, R.D. and Chauhan, B.L. (1990) Br. J. Clin. Pharmacol., 30, 779-783.
56. Kleyn, P.W. and Vesell, E.S. (1998) Science, 281, 1820-1821.
57. Evans, W.E. (1993) Science, 286, 487-491.
58. Marshall, E. (1999) Science, 284, 406-407.
59. The International SNP Map Working Group (2001) Nature, 409, 928-933.
60. Pfrost, D.R., Boyce-Jacino, M.T. and Grant, D.M. (2000) TIBTECH, 18, 334-338.
61. Sadee, W. (1998) Pharm. Res., 15, 959-963.
62. Aronson, J.K., Derry, S. and Loke, Y.K. (2002) Fundam. Clin. Pharmacol., 16, 49-56.
63. Edwards, I.R and Aronson, J.K. (2000) Lancet, 356, 1255-1259.
64. Pirmohamed, P. and Park, B.K. (2001) Trends in Pharmacological Sciences, 22, 298-305.
65. Rawlins, M.D. and Thompson, J.W. (1991) Mechanisms of Adverse Drug Reactions. In Textbook of Adverse Drug Reactions (Davies, D.M. ed.) pp 18-45, Oxford Press.
66. Einarson, T.R. (1993) Ann. Pharmacother., 27, 882-840.
67. Marshall, A. (1997) Nat. Biotechnology, 15, 1249-1252.
68. Meyer, U.A. (2000) Lancet, 356, 1667-1671.
69. Nebert, D.W. (1997) Am. J. Hum. Genetics, 60, 265-271.
70. Nebert, D.W. and Bingham, E. (2001) Trends in Biotechnology, 19, 519-523.
71. Gonzales, F.J. (1994) Clin. Pharmacokinetics, 26, 59-70.
72. Cho, R.J., FromontRacine, M., Wodicka, L., Feierbach, B., Stearns, T., Legrain, P., Lockhart, D.J. and Davis, R.W. (1998) Proc. Natl. Acad. Sci. (USA), 95, 3752-3757.
73. Marshall, A. and Hodgson, J. (1998) Nat. Biotechnology, 16, 23-31.
74. Nebert, D.W. (1997) Pharmacogenetics, 7, 435-440.
75. Flockhart, D. (1998) Pharmacogenetics in Cardiology: Pharmacogenetic in patient care conference by AACC on Nov 6.
76. Taube, J., Halsall, D. and Baglin, T. (2000) Blood, 96, 816-1819.
77. Lai, E., Riley, J., Purvis, I, Roses, A. (1998) Genomics, 54, 31-38.
78. Goldenberg, M.M. (1999) Clin. Therapeutics, 21, 309-318.
79. Baselge, J., Norton, L., Albanell, J., Kim, Y.M. and Mendelsohn, J. (1998) Cancer Res., 58, 2825-2831.
80. Rodrigues, A.D. and Roberts, E.M. (1997) Drug Metab. Dispos., 25, 651-655.
81. Guengerich, F. (1998) Environment Health Perspect., 106, 365-368.
82. Motulsky, A.G. (1978) Human Genetics Supplement, 1,1
83. Dahl, A.K. and Bertilsson, L. (1993) Pharmacogenetics, 3, 61-70.